Location History:
- Tokyo, JP (2008)
- Minato-ku, JP (2014)
Company Filing History:
Years Active: 2008-2014
Title: Oh Yoshida: Innovator in Breast Cancer Resistance Inhibitors
Introduction
Oh Yoshida, an inventor based in Minato-ku, Japan, has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for breast cancer resistance proteins. With a portfolio that includes two patents, Yoshida's work stands out for its innovative approach to tackling breast cancer.
Latest Patents
Yoshida’s latest patents focus on the formulation of a BCRP/ABCG2 inhibitor, which plays a crucial role in overcoming chemotherapy resistance in breast cancer treatment. The primary invention is a drug that effectively inhibits the breast cancer resistance protein, featuring an active ingredient that is an acrylonitrile derivative or a salt thereof. Additionally, another patent elaborates on a breast cancer resistance protein inhibitor containing a diphenylacrylonitrile derivative, characterized by a complex arrangement of functional groups, enhancing its efficacy against the BCRP.
Career Highlights
Throughout his career, Oh Yoshida has worked with Kabushiki Kaisha Yakult Honsha, where his research has contributed to the development of groundbreaking therapeutic strategies in oncology. His commitment to researching potential solutions to drug resistance in cancer treatment has positioned him as a key figure in pharmaceutical innovations.
Collaborations
Yoshida collaborates with talented researchers such as Ryuta Yamazaki and Yukiko Nishiyama, demonstrating the importance of teamwork in advancing medical innovation. Their collective expertise contributes to the successful development of therapies that could significantly improve patient outcomes in breast cancer treatment.
Conclusion
Oh Yoshida's pioneering efforts in the field of breast cancer resistance inhibitors represent a remarkable stride in medical advancements. With his innovative patents and collaborative work, he exemplifies the impact that dedicated inventors can have in enriching the landscape of cancer therapeutics. Through continued research and development, Yoshida's contributions may pave the way for new and effective treatment options for patients facing breast cancer.